Karsten Krakow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karsten Krakow has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
C. Otoul
From the Epilepsy Research Group, Department of Clinical Neurology, Institute of Neurology, University College London, and the National Society for Epilepsy (Drs. Krakow, Walker, and Sander), Chalfont St. Peter, UK; the Department of Neurology (Dr. Krakow), Goethe University, Frankfurt, Germany; and UCB S.A. (Dr. Otoul), Braine l’Alleud, Belgium
1 shared publicationC.A Scott
1 shared publicationD.R. Fish
1 shared publicationE.A Maguire
1 shared publicationE.S Krishnamoorthy
1 shared publicationG. Holder
1 shared publication
Latest Publications
- 1 June 2008
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 5 (5) , 286-295
Imaging Epileptic Activity Using Functional MRI
This review concentrates on functional MRI (fMRI) methods to identify the epileptic focus, i.e. ictal and interictal fMRI. First, established clinical applications of fMRI in the field of epilepsy are briefly introduced: fMRI of sensorimotor, language and memory function can already be considered as clinically relevant tools to identify the eloquent cortex and to predict postoperative functional deficits in patients considered for epilepsy surgery. fMRI offers a valid alternative to invasive methods like the Wada test for establishing language dominance, and it is likely that it will also replace the Wada test for assessing presurgical memory function in the nearer future. Ictal fMRI (fMRI studies of epileptic seizures) will remain confined to exceptional cases due to practical limitations. The generators of interictal epileptiform discharges (IED) can be studied with EEG-correlated fMRI. Despite its technical challenges, it has proved useful to provide insights into the generation of IED in patients with focal and generalized epilepsy. In selected patients with focal IED, EEG-correlated fMRI has the potential to reproducibly identify cortical areas involved in generating IED, i.e. the irritative zone. In patients with generalizes IED, suspension of functional networks due to the IED can be demonstrated. The utility of EEG-correlated fMRI in clinical epileptology cannot be definitely determined yet.
- 1 June 2008
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 5 (5) , 286-295
Imaging Epileptic Activity Using Functional MRI
This review concentrates on functional MRI (fMRI) methods to identify the epileptic focus, i.e. ictal and interictal fMRI. First, established clinical applications of fMRI in the field of epilepsy are briefly introduced: fMRI of sensorimotor, language and memory function can already be considered as clinically relevant tools to identify the eloquent cortex and to predict postoperative functional deficits in patients considered for epilepsy surgery. fMRI offers a valid alternative to invasive methods like the Wada test for establishing language dominance, and it is likely that it will also replace the Wada test for assessing presurgical memory function in the nearer future. Ictal fMRI (fMRI studies of epileptic seizures) will remain confined to exceptional cases due to practical limitations. The generators of interictal epileptiform discharges (IED) can be studied with EEG-correlated fMRI. Despite its technical challenges, it has proved useful to provide insights into the generation of IED in patients with focal and generalized epilepsy. In selected patients with focal IED, EEG-correlated fMRI has the potential to reproducibly identify cortical areas involved in generating IED, i.e. the irritative zone. In patients with generalizes IED, suspension of functional networks due to the IED can be demonstrated. The utility of EEG-correlated fMRI in clinical epileptology cannot be definitely determined yet.
- 26 June 2001
- Published by Wolters Kluwer Health in Neurology
- Vol. 56 (12) , 1772-1774
Long-term continuation of levetiracetam in patients with refractory epilepsy
The long-term continuation (retention) rate, efficacy, and safety data of the new antiepileptic drug levetiracetam (LEV) was evaluated in all patients with epilepsy exposed to the drug during its developmental program (n = 1,422). The retention rate was estimated to be 60% after 1 year and 32% after 5 years. Thirty-nine percent (512/1,325) of patients had a seizure reduction of ≥50%, and 13% (183/1,422) became seizure-free for at least 6 months. LEV seems an effective and well tolerated new antiepileptic drug.
- 26 June 2001
- Published by Wolters Kluwer Health in Neurology
- Vol. 56 (12) , 1772-1774
Long-term continuation of levetiracetam in patients with refractory epilepsy
The long-term continuation (retention) rate, efficacy, and safety data of the new antiepileptic drug levetiracetam (LEV) was evaluated in all patients with epilepsy exposed to the drug during its developmental program (n = 1,422). The retention rate was estimated to be 60% after 1 year and 32% after 5 years. Thirty-nine percent (512/1,325) of patients had a seizure reduction of ≥50%, and 13% (183/1,422) became seizure-free for at least 6 months. LEV seems an effective and well tolerated new antiepileptic drug.
- 1 November 2000
- Published by Elsevier in Epilepsy Research
- Vol. 42 (1) , 1-6
Fixation-off sensitivity as a model of continuous epileptiform discharges: electroencephalographic, neuropsychological and functional MRI findings
- 1 November 2000
- Published by Elsevier in Epilepsy Research
- Vol. 42 (1) , 1-6
Fixation-off sensitivity as a model of continuous epileptiform discharges: electroencephalographic, neuropsychological and functional MRI findings
- 1 June 2000
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 9 (4) , 287-290
Recovery of visual field constriction following discontinuation of vigabatrin
- 1 June 2000
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 9 (4) , 287-290
Recovery of visual field constriction following discontinuation of vigabatrin